SR 304 Georgia Senate · 2023-2024 Regular Session

RSV Immunization Technologies; vaccines and monoclonal antibodies within the federal VFC program; support the inclusion

Summary
A RESOLUTION supporting the inclusion of new RSV immunization technologies, including vaccines and monoclonal antibodies, within the federal VFC program; and for other purposes.
Bill status passed 3 of 5 stages cleared
Introduction
Mar 2023
Committee Review
Senate Passage
Mar 2023
House Passage
Governor
Introduced Mar 13, 2023 Last action Mar 14, 2023
Floor votes

How they voted

This bill passed the Senate by voice vote (no roll call recorded).
Full legislative history

Actions timeline

Total actions
2
Key actions
1
Committee
0
Mar 14, 2023
Upper · Passed
Senate Read and Adopted
upper
Mar 13, 2023
Introduced
Senate Hopper
upper
9 primary · 0 co-sponsors

Sponsors